Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel dose-escalation study for post-COVID brain fog
jRCTs031250725Recruiting
- Sponsor
- Ampametry
- Start
- Mar 2026
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of perampanel in post-COVID syndrome, sponsored by Ampametry. Primary endpoint: Occurrence of adverse events. Started Mar 2026; status: recruiting.
02
Drugs
perampanel
03
Conditions
post-COVID syndrome
Beyond the preview
Go deeper on jRCTs031250725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250725.